|
|
Article: GSK Consumer Healthcare Launches Suit to Stop Misleading Marketing of Unproven Herbal Smoking Cessation Therapy; - GlaxoSmithKline Calls for End to False Promises to Smokers Looking to Quit -.
- Article from:
- PR Newswire
- Article date:
- February 8, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PITTSBURGH, Feb. 8 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare filed suit today in Federal district court to seek an injunction against Nicodrops, Inc., the maker of Nicodrops, for false claims relating to the safety and efficacy of its so-called smoking cessation system. There is no proof that any herbal ingredient in Nicodrops, or the Nicodrops product itself, is a safe or effective therapy for smoking cessation, yet the company is making safety and efficacy claims.(1) Nicodrops and any other products making health claims as a drug should be subject to the same, rigorous FDA review process as GSK Consumer Healthcare's nicotine replacement therapies, ...